Aspen Aerogels, Inc. Reports Second Quarter 2024 Financial Results and Recent Business Highlights
Rhea-AI Summary
Aspen Aerogels (NYSE: ASPN) reported record Q2 2024 revenues of $117.8 million, up 25% QoQ and 145% YoY. The company achieved net income of $16.8 million ($0.21 per diluted share) and Adjusted EBITDA of $28.9 million. Key highlights include:
- Thermal Barriers revenue: $80.8 million (+24% QoQ, +540% YoY)
- Energy Industrial revenue: $36.9 million (+27% QoQ, +4% YoY)
- Gross margins improved to 44%
- Cash generated from operations: $6.8 million
Aspen increased its 2024 outlook, projecting revenue over $390 million (+63% YoY), net income exceeding $7 million, and Adjusted EBITDA above $60 million. The company remains positioned to capture additional revenues as automotive OEM customers ramp up production and Energy Industrial product supply increases.
Positive
- Record quarterly revenues of $117.8 million, up 145% year-over-year
- Achieved net income of $16.8 million, compared to a net loss in Q2 2023
- Adjusted EBITDA of $28.9 million, a significant improvement from $(10.8) million in Q2 2023
- Gross margins improved to 44%, a 26-percentage point increase year-over-year
- Cash generated from operations of $6.8 million in the quarter
- Increased 2024 revenue outlook to over $390 million, representing 63% year-over-year growth
- Raised 2024 net income outlook to over $7 million and Adjusted EBITDA outlook to over $60 million
Negative
- Energy Industrial segment remains supply constrained, limiting potential revenue growth
News Market Reaction 1 Alert
On the day this news was published, ASPN gained 16.00%, reflecting a significant positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Record quarterly revenues of
Delivered
Increased 2024 revenue and profitability outlook for the second consecutive quarter
Total revenue for the second quarter of 2024 was
Adjusted EBITDA for the second quarter of 2024 was
Recent Business Highlights & Quarterly Performance
- Company revenue of
, up$117.8 million 25% quarter-over-quarter (QoQ) and145% year-over-year (YoY)- Thermal Barriers:
of revenue, up$80.8 million 24% QoQ and540% YoY - Energy Industrial:
of supply constrained revenue, up$36.9 million 27% QoQ and4% YoY
- Thermal Barriers:
- Energy Industrial segment remains on path to deliver over
of revenue in 2024; shipped$150 million of revenue from our external manufacturing facility in Q2, an increase of$28.3 million 94% QoQ. Carbon capture projects are beginning to present additional market opportunities. - Delivered gross margins of
44% , a 7-percentage point improvement QoQ and 26-percentage point improvement YoY - Net income of
, an$16.8 million improvement QoQ and$18.7 million improvement YoY$32.2 million - Adjusted EBITDA of
($28.9 million 25% margin), a or$16.0 million 124% improvement QoQ and improvement YoY$39.8 million - Operating income of
, a$20.0 million improvement or$17.6 million 720% QoQ and improvement YoY$37.0 million - Cash generated from operations of
in the quarter$6.8 million - Ended second quarter of 2024 with cash and equivalents of
$91.4 million
"This quarter's results demonstrate the significant operating leverage of our business model as we continue to utilize a higher percentage of our current capacity and effectively execute our strategy," commented Don Young,
Updated 2024 Financial Outlook
($ in millions, except per share amounts) | ||||
Metric | Prior 2024 Outlook | Current 2024 Outlook | Δ Prior | |
Revenue YoY Growth | >380 | >390 | 10
| |
Net Income | >2 | >7 | 5 | |
Adjusted EBITDA | >55 | >60 | 5 | |
Earnings Per Share (Diluted) | >0.03 | >0.09 | 0.06 | |
The Company's 2024 outlook assumes depreciation and amortization of
Ricardo C. Rodriguez, Chief Financial Officer and Treasurer noted, "We remain ready to capture additional revenues as our automotive OEM customers win their fair share of the market and as we increase our Energy Industrial product supply. Providing additional context to our updated outlook, we continue planning objectively around the production track record of our OEM customers, the tightening global emissions regulatory environment, and an EV market that favors recently launched models, many of which are equipped with PyroThin®. We believe that delivering results as demand presents itself, versus attempting to calculate outsized upside expectations, makes the most sense."
A reconciliation of net income to Adjusted EBITDA for the 2024 financial outlook is provided in the financial schedules that are part of this press release. An explanation of this non-GAAP financial measure is also included below under the heading "Non-GAAP Financial Measures."
ATVM Department of Energy Loan Status Update
Late last year, we announced that the
Last Twelve-Month Financial Comparison
A comparison of key financial metrics for the trailing twelve-month periods ended June 30, 2023 and 2024:
($ in millions) | ||||||
Metric | LTM Q2 2023 | LTM Q2 2024 | Delta | % Improvement | ||
Revenue | 190 | 357 | 167 | 88 % | ||
Gross Profit | 21 | 130 | 109 | 506 % | ||
% Margin | 11 % | 36 % | ||||
Net Income (Loss) | (71) | 1 | 72 | 102 % | ||
% Margin | (38 %) | 0 % | ||||
Adjusted EBITDA | (52) | 44 | 96 | 183 % | ||
% Margin | (28 %) | 12 % | ||||
Operating Income | (74) | 9 | 83 | 112 % | ||
% Margin | (39 %) | 3 % | ||||
Total CAPEX | 241 | 111 | (130) | 54 % | ||
Conference Call and Webcast Notification
A conference call with
Shareholders and other interested parties may call +1 (833) 470-1428 (domestic) or +1 (929) 526-1599 (international) and reference conference ID "517793" to participate in the conference call. In addition, the conference call and an accompanying slide presentation will be available live as a listen-only webcast hosted at the Investors section of
Following the live event, an archived version of the webcast will be available on
Non-GAAP Financial Measures
In addition to providing financial measurements based on generally accepted accounting principles in
Management believes that this non-GAAP financial measure reflects
The non-GAAP financial measure does not replace the presentation of
About Aspen Aerogels, Inc.
Special Note Regarding Forward-Looking and Cautionary Statements
This press release and any related discussion contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties that could cause actual results to be materially different from historical results or from any future results expressed or implied by such forward-looking statements, including statements relating to
ASPEN AEROGELS, INC. Condensed Consolidated Balance Sheets (Unaudited and in thousands)
| ||||||||
June 30, | December 31, | |||||||
2024 | 2023 | |||||||
(In thousands) | ||||||||
Assets | ||||||||
Current assets: | ||||||||
Cash and cash equivalents | $ | 91,381 | $ | 139,723 | ||||
Restricted cash | 394 | 248 | ||||||
Accounts receivable, net | 116,928 | 69,995 | ||||||
Inventories | 53,030 | 39,189 | ||||||
Prepaid expenses and other current assets | 26,804 | 17,176 | ||||||
Total current assets | 288,537 | 266,331 | ||||||
Property, plant and equipment, net | 437,973 | 417,227 | ||||||
Operating lease right-of-use assets | 18,671 | 17,212 | ||||||
Other long-term assets | 3,448 | 2,278 | ||||||
Total assets | $ | 748,629 | $ | 703,048 | ||||
Liabilities and Stockholders' Equity | ||||||||
Current liabilities: | ||||||||
Accounts payable | $ | 57,246 | $ | 51,094 | ||||
Accrued expenses | 19,684 | 22,811 | ||||||
Deferred revenue | 3,095 | 2,316 | ||||||
Finance obligation for sale and leaseback transactions | 1,254 | — | ||||||
Operating lease liabilities | 2,151 | 1,874 | ||||||
Total current liabilities | 83,430 | 78,095 | ||||||
Convertible note - related party | 121,074 | 114,992 | ||||||
Finance obligation for sale and leaseback transactions long-term | 3,224 | — | ||||||
Operating lease liabilities long-term | 23,074 | 21,906 | ||||||
Total liabilities | 230,802 | 214,993 | ||||||
Stockholders' equity: | ||||||||
Total stockholders' equity | 517,827 | 488,055 | ||||||
Total liabilities and stockholders' equity | $ | 748,629 | $ | 703,048 | ||||
ASPEN AEROGELS, INC. Consolidated Statements of Operations (Unaudited and in thousands, except share and per share data)
| ||||||||||||||||
Three Months Ended | Six Months Ended | |||||||||||||||
June 30, | June 30, | |||||||||||||||
2024 | 2023 | 2024 | 2023 | |||||||||||||
(In thousands, except | ||||||||||||||||
Revenue | $ | 117,770 | $ | 48,158 | $ | 212,271 | $ | 93,744 | ||||||||
Cost of revenue | 66,192 | 39,751 | 125,550 | 80,251 | ||||||||||||
Gross profit | 51,578 | 8,407 | 86,721 | 13,493 | ||||||||||||
Operating expenses: | ||||||||||||||||
Research and development | 4,565 | 3,964 | 9,054 | 8,063 | ||||||||||||
Sales and marketing | 9,521 | 8,127 | 17,824 | 15,840 | ||||||||||||
General and administrative | 17,506 | 13,360 | 34,719 | 25,542 | ||||||||||||
Impairment of equipment under development | — | — | 2,702 | — | ||||||||||||
Total operating expenses | 31,592 | 25,451 | 64,299 | 49,445 | ||||||||||||
Income (loss) from operations | 19,986 | (17,044) | 22,422 | (35,952) | ||||||||||||
Other income (expense) | ||||||||||||||||
Interest expense, convertible note - related party | (3,043) | (211) | (6,081) | (486) | ||||||||||||
Interest income (expense) | 741 | 1,832 | 264 | 4,219 | ||||||||||||
Total other income (expense) | (2,302) | 1,621 | (5,817) | 3,733 | ||||||||||||
Income (loss) before income tax expense | 17,684 | (15,423) | 16,605 | (32,219) | ||||||||||||
Income tax expense | (866) | — | (1,622) | — | ||||||||||||
Net income (loss) | $ | 16,818 | $ | (15,423) | $ | 14,983 | $ | (32,219) | ||||||||
Net income (loss) per share: | ||||||||||||||||
Basic | $ | 0.22 | $ | (0.22) | $ | 0.20 | $ | (0.47) | ||||||||
Diluted | $ | 0.21 | $ | (0.22) | $ | 0.19 | $ | (0.47) | ||||||||
Weighted-average common shares outstanding: | ||||||||||||||||
Basic | 76,336,811 | 69,249,281 | 76,049,852 | 69,206,249 | ||||||||||||
Diluted | 78,981,383 | 69,249,281 | 78,749,199 | 69,206,249 | ||||||||||||
Analysis of Cash Flow
The following table summarizes our cash flows for the periods indicated.
Three Months Ended | ||||||||
March 31, 2024 | June 30, 2024 | |||||||
(In thousands) | ||||||||
Net cash provided by (used in): | ||||||||
Operating activities | $ | (17,749) | $ | 6,843 | ||||
Investing activities | (25,863) | (24,827) | ||||||
Financing activities | 5,259 | 8,141 | ||||||
Net (decrease) increase in cash | (38,353) | (9,843) | ||||||
Cash, cash equivalents and restricted cash at beginning of period | 139,971 | 101,618 | ||||||
Cash, cash equivalents and restricted cash at end of period | $ | 101,618 | $ | 91,775 | ||||
Reconciliation of Non-GAAP Financial Measures
The following tables present a reconciliation of the non-GAAP financial measure included in this press release to the most directly comparable GAAP measure:
Reconciliation of Adjusted EBITDA to Net income (loss)
We define Adjusted EBITDA as net income (loss) before interest expense, taxes, depreciation, amortization, stock-based compensation expense and other items, which occur from time to time and which we do not believe are indicative of our core operating performance.
For the three and six months ended June 30, 2024 and 2023:
Three Months Ended | Six Months Ended | |||||||||||||||
June 30, | June 30, | |||||||||||||||
2024 | 2023 | 2024 | 2023 | |||||||||||||
(In thousands) | ||||||||||||||||
Net income (loss) | $ | 16,818 | $ | (15,423) | $ | 14,983 | $ | (32,219) | ||||||||
Depreciation and amortization | 5,986 | 3,503 | 11,772 | 6,207 | ||||||||||||
Stock-based compensation | 2,971 | 2,710 | 7,677 | 4,977 | ||||||||||||
Other expense (income) | 2,302 | (1,621) | 5,817 | (3,733) | ||||||||||||
Income tax expense | 866 | - | 1,622 | - | ||||||||||||
Adjusted EBITDA | $ | 28,943 | $ | (10,831) | $ | 41,871 | $ | (24,768) | ||||||||
For the trailing twelve months ended June 30, 2024 and 2023:
Last Twelve Months | ||||||||
June 30, | ||||||||
2024 | 2023 | |||||||
(In thousands) | ||||||||
Net income (loss) | $ | 1,391 | $ | (71,423) | ||||
Depreciation and amortization | 20,883 | 11,268 | ||||||
Stock-based compensation | 13,654 | 10,239 | ||||||
Other expense (income) | 6,158 | (2,504) | ||||||
Income tax expense | 1,622 | - | ||||||
Adjusted EBITDA | $ | 43,708 | $ | (52,420) | ||||
For the 2024 full year financial outlook:
Year Ending | ||||||||
December 31, 2024 | ||||||||
Current | Prior | |||||||
(In thousands) | ||||||||
Net income | $ | 7,000 | $ | 2,000 | ||||
Depreciation and amortization | 30,000 | 30,000 | ||||||
Stock-based compensation | 14,000 | 14,000 | ||||||
Other expense, net and income tax expense | 9,000 | 9,000 | ||||||
Adjusted EBITDA | $ | 60,000 | $ | 55,000 | ||||
View original content:https://www.prnewswire.com/news-releases/aspen-aerogels-inc-reports-second-quarter-2024-financial-results-and-recent-business-highlights-302217108.html
SOURCE Aspen Aerogels, Inc.